LXR agonism for CNS diseases: promises and challenges
Date
2024-04-16
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Abstract
The unfavorable prognosis of many neurological conditions could be attributed to limited tissue regeneration in central nervous system (CNS) and overwhelming inflammation, while liver X receptor (LXR) may regulate both processes due to its pivotal role in cholesterol metabolism and inflammatory response, and thus receives increasing attentions from neuroscientists and clinicians. Here, we summarize the signal transduction of LXR pathway, discuss the therapeutic potentials of LXR agonists based on preclinical data using different disease models, and analyze the dilemma and possible resolutions for clinical translation to encourage further investigations of LXR related therapies in CNS disorders.
Graphical Abstract
Description
Keywords
Citation
Journal of Neuroinflammation. 2024 Apr 16;21(1):97